Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Erythema nodosum leprosum (type 2 reaction) in a patient with neurofibromatosis type 1.

George R, D'Souza S, Masoodi I. BMJ case reports. 2022;
Publication

Case of leprosy mimicking preseptal cellulitis: a diagnostic dilemma.

Sarkar D, Chawla H, Singh P, et al. BMJ case reports. 2022;
Publication

Experience in receiving and practicing self-care as a person affected by leprosy

Choudhury SM. Lepra. Leprosy Review. 2021; 92 (4) : 379-384.
Download PDF
Publication

A unique case of borderline lepromatous leprosy presenting with both hypopigmented and hyperpigmented macules

Abideen F, Balakrishnan S, Sindhu CB, et al. Lepra. Leprosy Review. 2021; 92 (4) : 412-420.
Download PDF
Publication

A Comprehensive Rehabilitation of a known Case of Leprosy Operated for Midshaft Femur Fracture

Vaidya L, Bawiskar D, Upadhyay P, et al. Sciencedomain International. Journal of Pharmaceutical Research International. 2021;
Download PDF
Publication

Self-care in leprosy at the front line

Darlong J. Lepra. Leprosy Review. 2021; 92 (4) : 356-365.
Download PDF
Publication

Leprosy Mimicking as Rheumatoid Arthritis: A Case Report

Sridana ME, Kurniari PK, Kambayana G. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2021; 9 (C) : 277-279.
Download PDF
Publication

A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine

Sachdeva S, Sinha S, Sardana K. Medknow. International Journal of Mycobacteriology. 2021; 10 (4) : 472.
Download PDF
Publication

A clinicoepidemiological study of psychiatric co-morbidity in Hansen's Disease

Verma G, Rani R, Tegta G, et al. Medknow. Indian Dermatology Online Journal. 2021; 12 (6) : 847.
Download PDF
Publication

Efficacy of autologous smashed follicular dermal graft and epidermal cell suspension in the treatment of chronic nonhealing trophic ulcers in Hansen's patients

Dheemant M, Yadalla H, Raju B. Medknow. Indian Dermatology Online Journal. 2021; 12 (6) : 868.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 82
  • Next page ››
Subscribe to South-East Asia Region (SEAR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD